Shopping Cart 0
Cart Subtotal
USD 0

Denovo Biopharma LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Denovo Biopharma LLC (Denovo Biopharma), formerly Denovo Biomarkers Inc is a biotechnology company that provides novel biomarker solutions to personalize drug development. The company enables drug developers to design new clinical trials in targeted patient population and re-evaluates medicines failed in general patient populations. Its core technology performs genomic biomarker discovery using archived clinical samples. Denovo Biopharma supports its partners throughout the evolution process up to approval and launch of the drug together with the companion diagnostic test. The company also partners with life science companies and drug developers. It has its operations in the US and China. Denovo Biopharma is headquartered in Wilmington, Delaware, the US.

Denovo Biopharma LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Denovo Biopharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Denovo Biopharma Acquires Global Rights to Enzastaurin from Eli Lilly 11

Venture Financing 12

Denovo Biopharma Raises Funds in Series A Financing Round 12

Partnerships 13

ALS Emergency Treatment Fund And Denovo Biomarkers Partner To Explore Personalized Medicine Approach For ALS Treatments 13

Licensing Agreements 14

Denovo Biopharma Enters into Licensing Agreement with Stanford University 14

Denovo Biopharma Enters into Licensing Agreement with Albany Molecular Research 15

Denovo Biopharma Enters into Licensing Agreement with Eli Lilly for Pomaglumetad Methionil 16

Denovo Biopharma LLC-Key Competitors 17

Denovo Biopharma LLC-Key Employees 18

Denovo Biopharma LLC-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Clinical Trials 20

Apr 03, 2018: First Patient Dosed In Pivotal Biomarker-Guided Phase 3 Study Of First Line Therapy With DB102 (enzastaurin) + R-CHOP In Patients With High-Risk Diffuse Large B-Cell Lymphoma 20

Oct 24, 2017: Denovo Biopharma Receives FDAs Permission to Proceed a Phase 3 Clinical Trial with DB102 (Enzastaurin) in the First Line Treatment of High Risk DLBCL 21

Feb 16, 2017: Denovo Biopharma plans to launch a Global Phase 3 Trial of DB102 (Enzastaurin) in Diffuse Large B-cell Lymphoma 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Key Facts 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Denovo Biopharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Denovo Biopharma LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Denovo Biopharma Acquires Global Rights to Enzastaurin from Eli Lilly 11

Denovo Biopharma Raises Funds in Series A Financing Round 12

ALS Emergency Treatment Fund And Denovo Biomarkers Partner To Explore Personalized Medicine Approach For ALS Treatments 13

Denovo Biopharma Enters into Licensing Agreement with Stanford University 14

Denovo Biopharma Enters into Licensing Agreement with Albany Molecular Research 15

Denovo Biopharma Enters into Licensing Agreement with Eli Lilly for Pomaglumetad Methionil 16

Denovo Biopharma LLC, Key Competitors 17

Denovo Biopharma LLC, Key Employees 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Denovo Biopharma LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Denovo Biopharma LLC (Denovo Biopharma), formerly Denovo Biomarkers Inc is a biotechnology company that provides novel biomarker solutions to personalize drug development. The company enables drug developers to design new clinical trials in targeted patient population and re-evaluates medicines failed in general patient populations. Its core technology performs genomic biomarker discovery using archived clinical samples. Denovo Biopharma supports its partners throughout the evolution process up to approval and launch of the drug together with the companion diagnostic test. The company also partners with life science companies and drug developers. It has its operations in the US and China. Denovo Biopharma is headquartered in Wilmington, Delaware, the US.

Denovo Biopharma LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Denovo Biopharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Denovo Biopharma Acquires Global Rights to Enzastaurin from Eli Lilly 11

Venture Financing 12

Denovo Biopharma Raises Funds in Series A Financing Round 12

Partnerships 13

ALS Emergency Treatment Fund And Denovo Biomarkers Partner To Explore Personalized Medicine Approach For ALS Treatments 13

Licensing Agreements 14

Denovo Biopharma Enters into Licensing Agreement with Stanford University 14

Denovo Biopharma Enters into Licensing Agreement with Albany Molecular Research 15

Denovo Biopharma Enters into Licensing Agreement with Eli Lilly for Pomaglumetad Methionil 16

Denovo Biopharma LLC-Key Competitors 17

Denovo Biopharma LLC-Key Employees 18

Denovo Biopharma LLC-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Clinical Trials 20

Apr 03, 2018: First Patient Dosed In Pivotal Biomarker-Guided Phase 3 Study Of First Line Therapy With DB102 (enzastaurin) + R-CHOP In Patients With High-Risk Diffuse Large B-Cell Lymphoma 20

Oct 24, 2017: Denovo Biopharma Receives FDAs Permission to Proceed a Phase 3 Clinical Trial with DB102 (Enzastaurin) in the First Line Treatment of High Risk DLBCL 21

Feb 16, 2017: Denovo Biopharma plans to launch a Global Phase 3 Trial of DB102 (Enzastaurin) in Diffuse Large B-cell Lymphoma 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Key Facts 2

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Denovo Biopharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Denovo Biopharma LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9

Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Denovo Biopharma Acquires Global Rights to Enzastaurin from Eli Lilly 11

Denovo Biopharma Raises Funds in Series A Financing Round 12

ALS Emergency Treatment Fund And Denovo Biomarkers Partner To Explore Personalized Medicine Approach For ALS Treatments 13

Denovo Biopharma Enters into Licensing Agreement with Stanford University 14

Denovo Biopharma Enters into Licensing Agreement with Albany Molecular Research 15

Denovo Biopharma Enters into Licensing Agreement with Eli Lilly for Pomaglumetad Methionil 16

Denovo Biopharma LLC, Key Competitors 17

Denovo Biopharma LLC, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Denovo Biopharma LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.